title: No mourning for the conventional antipsychotics: the dawn of the atypical agents.
abstract: As Markowitz et al. explain, the atypical antipsychotics should become the first-line agents for the treatment of schizophrenia. There is much to be learned about these drugs, but their displacement of the conventional antipsychotics will be a continuous process. The loss of the older drugs will not be mourned.
authors.affiliation: Medical University of South Carolina, Charleston 29425, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: DeVane
mesh_terms: D014150:Antipsychotic Agents / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*